ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening for atrial fibrillation with a 14-day patch-based continuous ECG monitor

Authors: Daniel E. Singer MD, Steven J. Atlas MD, Alan S. Go MD, Renato D. Lopes MD, PhD, Steven A. Lubitz MD, David D. McManus MD, James H. Revkin MD, Donna Mills RN, Lori A. Crosson PhD, Judith C. Lenane RN, Ronald S. Aronson MD.

Summary:

Rationale and design of the GUARD-AF trial.

Key Findings:

Study finding limited due to slow enrollment and COVID19 pandemic.

The content on iRhythm Academy is provided for general educational purposes only and should not be considered the exclusive source for this type of information. This training does not replace or supersede approved labeling. The content will be shared with physicians and healthcare professionals who seek a deeper understanding of the operation and use of iRhythm products and services with the intent of enhancing their knowledge of features and operations described in the clinician manuals. At all times, it is the professional responsibility of the physicians and healthcare professionals to exercise independent clinical judgment in a particular situation. The device and service functionality and programming described on iRhythm Academy are based on its products and services, and can be referenced in the labeling and reference manuals. This website is intended for healthcare professionals and not intended for patients or consumers.